Author:
Friedman Mark T.,West Kamille A.,Bizargity Peyman,Annen Kyle,Gur H. Deniz,Hilbert Timothy
Publisher
Springer International Publishing
Reference7 articles.
1. Chapuy CI, Nicholson RT, Aquad MD, Chapuy B, Laubach JP, Richardson PG, et al. Resolving the daratumumab interference with blood compatibility testing. Transfusion. 2015;55(6 Pt 2):1545–54.
2. DARZALEX® Prescribing Information. Janssen Biotech, Inc., Horsesham, PA. August 2020.
3. SARCLISA® Prescribing Information. Sanofi-Aventis U.S. LLC, Bridgewater, NJ. March 2021.
4. Nedelcu E, Hall C, Stoner A, Eichbaum Q, Meena-Leist C. Interference of anti-CD47 therapy with blood bank testing. Transfusion. 2017;57(Suppl S3):148A.
5. Sher T, Fenton B, Akhtar A, Gertz MA. First report of safety and efficacy of daratumumab in two cases of advanced immunoglobulin light chain amyloidosis. Blood. 2016;128:1987–9.